BADGER METER INC (BMI)

US0565251081 - Common Stock

217.72  -0.74 (-0.34%)

After market: 217.72 0 (0%)

Fundamental Rating

7

Taking everything into account, BMI scores 7 out of 10 in our fundamental rating. BMI was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. BMI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BMI shows excellent growth, but is valued quite expensive already. Finally BMI also has an excellent dividend rating. These ratings could make BMI a good candidate for dividend and growth and quality investing.



9

1. Profitability

1.1 Basic Checks

BMI had positive earnings in the past year.
BMI had a positive operating cash flow in the past year.
In the past 5 years BMI has always been profitable.
In the past 5 years BMI always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of BMI (14.82%) is better than 95.20% of its industry peers.
With an excellent Return On Equity value of 20.12%, BMI belongs to the best of the industry, outperforming 89.60% of the companies in the same industry.
BMI has a Return On Invested Capital of 16.98%. This is amongst the best in the industry. BMI outperforms 94.40% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BMI is significantly above the industry average of 8.74%.
The 3 year average ROIC (14.02%) for BMI is below the current ROIC(16.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.82%
ROE 20.12%
ROIC 16.98%
ROA(3y)11.8%
ROA(5y)11.43%
ROE(3y)16.02%
ROE(5y)15.19%
ROIC(3y)14.02%
ROIC(5y)13.42%

1.3 Margins

BMI has a better Profit Margin (14.80%) than 91.20% of its industry peers.
BMI's Profit Margin has improved in the last couple of years.
BMI has a Operating Margin of 18.76%. This is amongst the best in the industry. BMI outperforms 96.80% of its industry peers.
BMI's Operating Margin has improved in the last couple of years.
BMI has a Gross Margin of 39.55%. This is in the better half of the industry: BMI outperforms 69.60% of its industry peers.
In the last couple of years the Gross Margin of BMI has remained more or less at the same level.
Industry RankSector Rank
OM 18.76%
PM (TTM) 14.8%
GM 39.55%
OM growth 3Y3.07%
OM growth 5Y4.11%
PM growth 3Y4.34%
PM growth 5Y15.47%
GM growth 3Y-0.2%
GM growth 5Y0.98%

8

2. Health

2.1 Basic Checks

BMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BMI has about the same amount of shares outstanding.
BMI has more shares outstanding than it did 5 years ago.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 21.29 indicates that BMI is not in any danger for bankruptcy at the moment.
BMI has a Altman-Z score of 21.29. This is amongst the best in the industry. BMI outperforms 95.20% of its industry peers.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.29
ROIC/WACC1.62
WACC10.48%

2.3 Liquidity

BMI has a Current Ratio of 4.10. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.10, BMI is doing good in the industry, outperforming 72.80% of the companies in the same industry.
A Quick Ratio of 2.87 indicates that BMI has no problem at all paying its short term obligations.
BMI has a Quick ratio of 2.87. This is in the better half of the industry: BMI outperforms 72.80% of its industry peers.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 2.87

7

3. Growth

3.1 Past

BMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.97%, which is quite impressive.
Measured over the past years, BMI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.31% on average per year.
Looking at the last year, BMI shows a very strong growth in Revenue. The Revenue has grown by 20.25%.
BMI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.16% yearly.
EPS 1Y (TTM)38.97%
EPS 3Y22.7%
EPS 5Y15.31%
EPS Q2Q%22.73%
Revenue 1Y (TTM)20.25%
Revenue growth 3Y18.25%
Revenue growth 5Y10.16%
Sales Q2Q%11.95%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.66% yearly.
BMI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.61% yearly.
EPS Next Y36.86%
EPS Next 2Y25.43%
EPS Next 3Y19.29%
EPS Next 5Y14.66%
Revenue Next Year17.02%
Revenue Next 2Y12.71%
Revenue Next 3Y10.86%
Revenue Next 5Y9.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 54.02, BMI can be considered very expensive at the moment.
BMI's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.73. BMI is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 44.07 indicates a quite expensive valuation of BMI.
BMI's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BMI to the average of the S&P500 Index (22.83), we can say BMI is valued expensively.
Industry RankSector Rank
PE 54.02
Fwd PE 44.07

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BMI is on the same level as its industry peers.
BMI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 48.99
EV/EBITDA 33.74

4.3 Compensation for Growth

BMI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BMI has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BMI's earnings are expected to grow with 19.29% in the coming years.
PEG (NY)1.47
PEG (5Y)3.53
EPS Next 2Y25.43%
EPS Next 3Y19.29%

7

5. Dividend

5.1 Amount

BMI has a yearly dividend return of 0.62%, which is pretty low.
BMI's Dividend Yield is rather good when compared to the industry average which is at 1.85. BMI pays more dividend than 85.60% of the companies in the same industry.
With a Dividend Yield of 0.62, BMI pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

The dividend of BMI is nicely growing with an annual growth rate of 12.13%!
BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
BMI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.13%
Div Incr Years18
Div Non Decr Years18

5.3 Sustainability

BMI pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
The dividend of BMI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.4%
EPS Next 2Y25.43%
EPS Next 3Y19.29%

BADGER METER INC

NYSE:BMI (12/20/2024, 8:04:00 PM)

After market: 217.72 0 (0%)

217.72

-0.74 (-0.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-17 2024-10-17/bmo
Earnings (Next)01-24 2025-01-24/amc
Inst Owners95.03%
Inst Owner Change1.71%
Ins Owners0.5%
Ins Owner Change-0.17%
Market Cap6.40B
Analysts73.33
Price Target221.53 (1.75%)
Short Float %3.23%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Dividend Growth(5Y)12.13%
DP28.4%
Div Incr Years18
Div Non Decr Years18
Ex-Date11-22 2024-11-22 (0.34)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.17%
Min EPS beat(2)-3.67%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)6.33%
Min EPS beat(4)-3.67%
Max EPS beat(4)19.54%
EPS beat(8)6
Avg EPS beat(8)8.03%
EPS beat(12)9
Avg EPS beat(12)8.32%
EPS beat(16)13
Avg EPS beat(16)7.72%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-2.72%
Max Revenue beat(2)5.44%
Revenue beat(4)2
Avg Revenue beat(4)2.11%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)6.63%
Revenue beat(8)6
Avg Revenue beat(8)4.21%
Revenue beat(12)9
Avg Revenue beat(12)3.78%
Revenue beat(16)12
Avg Revenue beat(16)2.97%
PT rev (1m)-1.9%
PT rev (3m)9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.88%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 54.02
Fwd PE 44.07
P/S 7.97
P/FCF 48.99
P/OCF 45.44
P/B 10.83
P/tB 14.99
EV/EBITDA 33.74
EPS(TTM)4.03
EY1.85%
EPS(NY)4.94
Fwd EY2.27%
FCF(TTM)4.44
FCFY2.04%
OCF(TTM)4.79
OCFY2.2%
SpS27.33
BVpS20.1
TBVpS14.53
PEG (NY)1.47
PEG (5Y)3.53
Profitability
Industry RankSector Rank
ROA 14.82%
ROE 20.12%
ROCE 22.38%
ROIC 16.98%
ROICexc 27.58%
ROICexgc 45.62%
OM 18.76%
PM (TTM) 14.8%
GM 39.55%
FCFM 16.26%
ROA(3y)11.8%
ROA(5y)11.43%
ROE(3y)16.02%
ROE(5y)15.19%
ROIC(3y)14.02%
ROIC(5y)13.42%
ROICexc(3y)19.32%
ROICexc(5y)17.53%
ROICexgc(3y)35.35%
ROICexgc(5y)31.15%
ROCE(3y)18.48%
ROCE(5y)17.73%
ROICexcg growth 3Y15.33%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y15.07%
ROICexc growth 5Y11.25%
OM growth 3Y3.07%
OM growth 5Y4.11%
PM growth 3Y4.34%
PM growth 5Y15.47%
GM growth 3Y-0.2%
GM growth 5Y0.98%
F-Score8
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 32.59%
Cap/Sales 1.27%
Interest Coverage 250
Cash Conversion 77.38%
Profit Quality 109.89%
Current Ratio 4.1
Quick Ratio 2.87
Altman-Z 21.29
F-Score8
WACC10.48%
ROIC/WACC1.62
Cap/Depr(3y)29.79%
Cap/Depr(5y)31.27%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.6%
Profit Quality(3y)117.92%
Profit Quality(5y)134.44%
High Growth Momentum
Growth
EPS 1Y (TTM)38.97%
EPS 3Y22.7%
EPS 5Y15.31%
EPS Q2Q%22.73%
EPS Next Y36.86%
EPS Next 2Y25.43%
EPS Next 3Y19.29%
EPS Next 5Y14.66%
Revenue 1Y (TTM)20.25%
Revenue growth 3Y18.25%
Revenue growth 5Y10.16%
Sales Q2Q%11.95%
Revenue Next Year17.02%
Revenue Next 2Y12.71%
Revenue Next 3Y10.86%
Revenue Next 5Y9.61%
EBIT growth 1Y39.05%
EBIT growth 3Y21.88%
EBIT growth 5Y14.69%
EBIT Next Year60.76%
EBIT Next 3Y24.86%
EBIT Next 5Y17.84%
FCF growth 1Y76.1%
FCF growth 3Y6.81%
FCF growth 5Y13.67%
OCF growth 1Y76.54%
OCF growth 3Y7.12%
OCF growth 5Y12.78%